The value of ovarian cancer screening.
Ovarian cancer is the commonest cause of death from a gynaecological malignancy. Diagnosis of the disease at an early stage is associated with significantly improved survival rate. This suggests that screening may impact on disease mortality. This review addresses the current methods of screening, the ongoing trials and future of screening for ovarian cancer.
Sharma
Aarti
A
Gynaecological Cancer Research Centre, Institute of Womens Health, University College London, London W1T 7DN.
Menon
Usha
U
D018394:CA-125 Antigen / Q000097:blood*; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging; D011237:Predictive Value of Tests; D012307:Risk Factors; D012680:Sensitivity and Specificity; D015996:Survival Rate; D014463:Ultrasonography
D018394:CA-125 Antigen